Covid: ok Aifa to obtain sixth ‘residual’ dose from J&J vaccine vials

Rome, May 28 (beraking latest news Salute) – Green light from the Italian Medicines Agency (Aifa) to extract a ‘sixth’ dose from Johnson & Johnson’s anti-Covid vaccine vials. The Italian Society of Hospital Pharmacy and Pharmaceutical Services of Healthcare Companies (Sifo) and the Italian Society of Preparatory Pharmacists (Sifap) today reported the okay of the Aifa, which had sent a request for authorization to the regulatory agency. ‘use of the residual quantity (the sixth dose) of the Janssen vaccine “in order to reduce waste and increase the number of doses (+ 20% in the case of J&J) available to operators employed in the vaccination campaign”. Hence the response of the ‘Drug agency that indicated “the opportunity to try to get as many doses as possible from each vial”.

The request was presented “in consideration of the fact – explain the hospital pharmacist societies – that a residual quantity is included in each vial which ensures the delivery of a complete additional 0.5 mL dose”. di Aifa, Nicola Magrini, it is specified that “the technical-scientific commission of the Agency underlines the opportunity to try to obtain as many doses as possible from each vial of vaccine, without prejudice to the guarantee of injecting each subject with the correct dose and the availability of adequate syringes. It is understood – warns the Cts Aifa – that any residues from different vials cannot be mixed “.